Jeffrey Mulhern

Changing incidence of glomerular diseases in adults

Gregory L. Braden, Jeffrey Mulhern, Michael H. O’Shea et al. · American Journal of Kidney Diseases · 2000 · 257 citations

Glomerular Disease, Glomerulonephritis, Hemodialysis +9

Results from part A of the multi-center, double-blind, randomized, placebo-controlled NefIgArd trial, which evaluated targeted-release formulation of budesonide for the treatment of primary immunoglobulin A nephropathy

Jonathan Barratt, Richard Lafayette, Jens Kristensen et al. · Kidney International · 2022 · 205 citations · Full text

Resistance training improves strength and functional measures in patients with end-stage renal disease

Samuel Headley, Michael J. Germain, Patrick Mailloux et al. · American Journal of Kidney Diseases · 2002 · 194 citations

Strength Training, Renal Function, Kinesiology +18

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 88 citations · Full text

Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients

Jeffrey Mulhern, Gregory L. Braden, Michael H. O’Shea et al. · American Journal of Kidney Diseases · 1995 · 71 citations

Hemodialysis, Urology, Medicine +9